BRIANA VOYTEK: Open Payments
NPI 1326665027 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 37 payments from 10 companies in 2025. Trend: 2023 $787 · 2024 $1,085 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $105 |
| Amgen Inc. | 6 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $90 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| BridgeBio Pharma, Inc. | 3 | $71 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: ELIQUIS, Repatha, JARDIANCE, LifeVest, LEQVIO, Attruby, Wegovy, FARXIGA.
Industry payments across PA — which companies pay providers there.
